top of page

Can You Regain Weight After Stopping Mounjaro?

  • Writer: Cole Rudolph
    Cole Rudolph
  • May 18
  • 5 min read

If you've been researching Mounjaro (tirzepatide) or you're already on treatment, there's a question that comes up sooner or later: What happens when I stop?

It's a fair thing to wonder. Mounjaro produces meaningful results for most people — reduced appetite, improved blood sugar control, and significant weight loss over time. But understanding what happens when the medication is discontinued is just as important as knowing how it works in the first place.

This article explains what the evidence shows about weight regain after stopping Mounjaro, why it happens, and what you can do to protect your progress long-term.


Why People Stop Mounjaro

There are many reasons someone might stop taking tirzepatide. Some are planned, others are not. Common reasons include:

  • Completing a planned treatment course

  • Cost or access challenges

  • Side effects that don't settle

  • Pregnancy or changes in health status

  • Feeling that the desired goal has been reached

Whatever the reason, it's worth knowing what to expect before making any changes — and always discussing it with your GP first.


What the Evidence Shows About Weight Regain

Clinical trial data on tirzepatide and related GLP-1 class medications is fairly clear on this point: stopping the medication is often followed by some degree of weight regain.

In discontinuation studies on GLP-1 and GIP/GLP-1 receptor agonists, participants who stopped treatment regained a significant portion of the weight they had lost within 12 months of stopping. The appetite-suppressing and metabolic effects of the medication are not permanent — they are tied to the drug being active in the body.

This doesn't mean the medication has "failed." It reflects something important about how obesity works biologically.


Why Weight Returns After Stopping

Weight regain after stopping tirzepatide isn't a personal failing — it's a physiological response that researchers have now documented across multiple GLP-1 class medications.

Here's why it happens:

Appetite regulation reverts. Mounjaro works by mimicking hormones that signal fullness and reduce hunger. When the medication leaves your system, hunger hormones gradually return to their previous levels. Food noise — that persistent background craving — can return.

Metabolic adaptation. The body has set-point mechanisms that drive weight back toward previous levels. When caloric restriction eases, the body responds by increasing appetite and, in some cases, reducing energy expenditure.

Lifestyle factors. If eating habits and activity levels haven't changed significantly during treatment, removing the medication's effect on appetite leaves fewer behavioural guardrails in place.

This is why obesity is increasingly understood as a chronic condition — one that often requires long-term management rather than a short course of treatment.


How Much Weight Might Come Back?

There's no single answer, because individual response varies considerably. However, the general pattern from research suggests:

  • Some weight regain is likely in most people who stop

  • The rate and amount varies depending on how much was lost, how long treatment continued, and what lifestyle changes were sustained

  • People who made meaningful dietary and activity changes during treatment tend to retain more of their progress than those who relied solely on the medication

It's also worth noting that the weight that returns is not always the same composition as what was lost. Lean mass preservation depends heavily on protein intake and exercise during the treatment period.


Does This Mean You Have to Take It Forever?

Not necessarily — but for many people, long-term use is clinically reasonable and, in some cases, recommended.

Obesity is recognised as a chronic condition with underlying hormonal and metabolic drivers. Just as someone with high blood pressure or type 2 diabetes may need ongoing treatment to maintain results, weight management for some people works best as a sustained programme rather than a finite course.

That said, some people do achieve lasting results — particularly those who have used the treatment window to establish lasting changes in eating patterns, physical activity, and relationship with food.

The decision about how long to stay on treatment is one to make with your doctor, based on your specific goals, health history, and circumstances. At Pocket Lab, our GPs support patients with exactly these kinds of conversations as part of our weight loss treatment programme.


How to Protect Your Progress If You Do Stop

If you and your GP decide it's appropriate to stop or pause Mounjaro, there are steps you can take to reduce the likelihood of significant regain:

Taper gradually if possible. Abrupt discontinuation can lead to a faster return of appetite. Your GP can advise on the safest approach for your situation.

Maintain a high-protein diet. Protein supports satiety and lean muscle retention. This is one of the most evidence-backed dietary strategies for weight maintenance.

Keep up regular physical activity. Muscle mass increases your resting metabolic rate. Resistance training in particular helps protect against regain.

Track your intake and weight. Awareness is a protective tool. Many people find that a small amount of monitoring helps them catch and course-correct early if weight begins to return.

Address emotional eating patterns. If stress, boredom, or emotional triggers played a role in weight gain previously, psychological support or behaviour change strategies can be valuable alongside or after medication.

Consider planned review appointments. Regular GP check-ins don't have to stop when medication does. Ongoing support improves long-term outcomes.


What About Restarting Treatment?

If weight does return after stopping, restarting tirzepatide is an option that many patients consider. The medication typically works again when reintroduced, and your GP can advise on the most appropriate dose to restart at based on how long you've been off it.

This is also a useful reminder that stopping and restarting is not a sign of failure — it's a clinical adjustment, like any other medication management decision.

If you're interested in what a Mounjaro programme looks like in practice in New Zealand, you can read more about how to get a Mounjaro prescription in NZ or find out how the medication works by visiting our overview of Mounjaro: how it works and side effects.


The Bottom Line for NZ Patients

Weight regain after stopping Mounjaro is common and, importantly, expected based on how the medication works. This is not a reason to avoid treatment — quite the opposite. It reinforces why ongoing GP support, lifestyle investment, and realistic expectations matter throughout the treatment journey.

If you're considering stopping, pausing, or restarting Mounjaro, the most important step is to talk with your doctor first. Making that decision with proper guidance makes a real difference to your outcomes.

Mounjaro is available in New Zealand through Pocket Lab's GP-led weight loss programme. Take a FREE eligibility quiz to find out if it's right for you.


This article is for informational purposes only and does not replace personalised medical advice. Always consult a registered New Zealand GP before making changes to your treatment.




 
 
bottom of page